A population-based case-control study to determine association of risk of mortality with adherence to antiplatelet agents, number of antiplatelet agents and antiplatelet regimens in patients undergoing stent placement or angioplasty
Latest Information Update: 21 Jan 2021
At a glance
- Drugs Aspirin (Primary) ; Cilostazol (Primary) ; Clopidogrel (Primary) ; Prasugrel (Primary) ; Ticagrelor (Primary) ; Ticlopidine (Primary) ; Triflusal (Primary) ; Antiplatelets
- Indications Cardiovascular disorders; Cerebrovascular disorders; Coronary artery disease
- Focus Therapeutic Use
- 21 Jan 2021 New trial record
- 01 Jan 2021 Results published in the Yonsei Medical Journal